🏛️ Verified NIH Record • Updated 2025-11-19

Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome (NCT05382156)

A Non-interventional Study to Assess the Long-term Safety and Efficacy of Osilodrostat in Patients With Endogenous Cushing's Syndrome

🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: RECORDATI GROUP

🩺 Plain-English Summary (8th-Grade Level)

This is a non-interventional, multinational, multi-centre study with primary data collection, to further document the safety and efficacy of osilodrostat administered in routine clinical practice in patients treated with osilodrostat for endogenous Cushing's Syndrome

Who can join: Review the eligibility criteria below.

Location: Barrow Neurological Institute — Phoenix, Arizona

Age range: 18 Years

🧪 Interventions in This Study

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (43 Sites)

Showing the first 25 of 43 sites.

  • Barrow Neurological Institute — Phoenix, Arizona
  • Emory University School — Atlanta, Georgia
  • Northwestern University — Chicago, Illinois
  • Indiana University Schl-med — Indianapolis, Indiana
  • St Elizabeth Physicians — Covington, Kentucky
  • Massachusetts General Hospital — Boston, Massachusetts
  • University of Michigan — Ann Arbor, Michigan
  • Mayo Clinic - Rochester — Rochester, Minnesota
  • Washington University School of Medicine — St Louis, Missouri
  • NYU Grossman School of Medicine — New York, New York
  • Memorial Sloan-Kettering Cancer Center (MSKCC) - New York — New York, New York
  • Endocrinology Research Associates, Inc. — Columbus, Ohio
  • Oregon Health And Science University — Portland, Oregon
  • University of Pennsylvania Medical Center — Philadelphia, Pennsylvania
  • Froedtert Hospital — Milwaukee, Wisconsin
  • Hôpital Haut-Lévêque — Bordeaux,
  • Hospices Civiles de Lyon — Bron,
  • CHU de Grenoble site Nord — Grenoble,
  • Groupement Hospitalier Sud - Hôpital Bicêtre — Le Kremlin-Bicêtre,
  • Hopital Claude Huriez - CHRU Lille — Lille,
  • Hopital de la Conception - APHM — Marseille,
  • Hôpital de Brabois — Nancy,
  • CHU de Nantes-Hopital Laennec — Nantes,
  • Hôpital Cochin — Paris,
  • Hopital Larrey — Toulouse,

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Endogenous Cushing's Syndrome clinical trials

💡 How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
🏛️ View Official NIH Record ↗